Inflammatory Myopathies
Ann Neurol 17:215-227, 317-3231985., Mastaglia,F.L.,et al, 1985
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019
Dysphagia and a rash
BMJ 361:k1590, McFarlane, M. & Disney, B., 2018
Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer
Neurol 91:e985-e994, Touat, M.,et al, 2018
Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016
Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014
Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013
Cancer-Associated Myositis and Anti-p155 Autoantibody in a Series of 85 Patients with Idiopathic Inflammatory Myopathy
Medicine 89:47-52, Trallero-Araguas,E.,et al, 2010
Polymyositis
Neurol 61:316-321, van der Meulen,M.F.G.,et al, 2003
Pituitary Carcinoma as a Cause of Acromegaly
NEJM 345:1645-1646, LeRoux,C.W.,et al, 2001
Dermatomyositis
Lancet 355:53-57, Callen,J.P., 2000
Herpes Simplex Encephalitis (HSE) and the Immunocompromised: A Clinical and Autopsy Study of HSE in the Settings of Cancer and Human Immunodeficiency Virus-Type 1 Infection
Hum Pathol 29:215-222, Schiff,D. &Rosenblum,M.K., 1998
Cavernous Sinus Syndrome
Arch Neurol 53:967-971, Keane,J.R., 1996
Risk of Second Brain Tumour after Conservative Surgery and Radiotherapy for Pituitary Adenoma
BMJ 304:1343-1346, Brada,M.,et al, 1992
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
NEJM 325:1487-1498, Dalakas,M.C., 1991
Current Concepts in the Idiopathic Inflammatory Myopathies:Polymyositis, Dermatomyositis, and Related Disorders
Ann Int Med 111:143-157, Plotz,P.H.,et al, 1989
The Frequency of Malignant Neoplasms in Patients with Polymyositis-Dermatomyositis, A Controlled Study
Arch Int Med 145:1835-1839, Manchul,L.A.,et al, 1985
Polymyositis & Dermatomyositis
NEJM 292:344, 1975, 292:403975., Bohan,A.,et al, 1975
Neurologic Manifestations of Progressive Systemic Sclerosis, 1972
Nebraska Med J 58:106, Aita,J.A., 1973